Senores Pharma.

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE0RB801010
NSEID: SENORES
BSEID: 544319

INR

550.80

34.6 (6.7%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.95 lacs

{
  "main_header": {
    "sid": 10039497,
    "name": "Senores Pharma.",
    "stock_name": "Senores Pharma.",
    "full_name": "Senores Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/senores-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "550.80",
    "chg": 34.6,
    "chgp": "6.7%",
    "dir": 1,
    "prev_price": "516.20",
    "mcapval": "2,536.63 Cr",
    "mcap": "Small Cap",
    "scripcode": "544319",
    "symbol": "SENORES",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE0RB801010",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:29 AM",
    "bse_nse_vol": "5.95 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Senores Pharmaceuticals Achieves 52-Week High Amid Strong Small-Cap Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-achieves-52-week-high-of-rs-664-amid-strong-trading-performance-1453374",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/SenoresPharmace_priceRelatedfactors_704516.png",
        "date": "2025-03-19 09:53:05",
        "description": "Senores Pharmaceuticals has achieved a new 52-week high of Rs. 664, reflecting a strong performance with a notable increase over the past three days. The stock is trading above multiple moving averages, indicating positive momentum, while the broader market shows small-cap stocks leading the gains."
      },
      {
        "title": "Senores Pharmaceuticals Achieves 52-Week High Amid Strong Small-Cap Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-achieves-52-week-high-of-rs-664-amid-strong-performance-1453392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/SenoresPharmace_priceRelatedfactors_704515.png",
        "date": "2025-03-19 09:53:05",
        "description": "Senores Pharmaceuticals has achieved a new 52-week high of Rs. 664, marking a significant milestone for the small-cap company in the Pharmaceuticals & Drugs sector. The stock has shown strong performance, trading above key moving averages and demonstrating substantial recovery from its previous low of Rs. 440."
      },
      {
        "title": "Senores Pharmaceuticals Achieves All-Time High Stock Price, Signaling Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-reaches-all-time-high-stock-price-of-rs-650-1453023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/SenoresPharmace_priceRelatedfactors_702958.png",
        "date": "2025-03-19 09:32:34",
        "description": "Senores Pharmaceuticals has achieved an all-time high stock price of Rs. 650, marking a significant milestone for the small-cap company. The stock has outperformed its sector and the broader market, showing strong upward trends and notable volatility, with impressive returns over the past week and year-to-date."
      },
      {
        "title": "Senores Pharmaceuticals Shows Strong Performance Amid Small-Cap Market Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-stock-rises-8-63-approaches-52-week-high-amid-market-surge-1430604",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/SenoresPharmace_priceRelatedfactors_699727.png",
        "date": "2025-03-18 15:16:12",
        "description": "Senores Pharmaceuticals has experienced notable activity, trading close to its 52-week high and showing strong performance in the small-cap pharmaceuticals sector. The stock has outperformed its sector and the broader market, reflecting a positive trend with significant gains over the past week and month."
      },
      {
        "title": "Senores Pharmaceuticals Faces Mixed Technical Indicators Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-technical-trend-shifts-from-upward-to-sideways-amid-stock-price-decline-1272219",
        "imagepath": "",
        "date": "2025-03-11 08:05:55",
        "description": "Senores Pharmaceuticals, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 551.00, down from a previous close of 566.10, with a 52-week high of 644.40 and a low of 440.00. Today's trading saw a high of 573.25 and a low of 540.85, indicating some volatility in its performance.\n\nIn terms of technical indicators, the company shows a mixed picture. The Moving Averages are being monitored closely, while other metrics such as MACD, RSI, and Bollinger Bands are also part of the ongoing analysis. Notably, the Dow Theory and On-Balance Volume (OBV) indicate no clear trend at this time.\n\nWhen comparing the stock's performance to the Sensex, Senores Pharmaceuticals has shown a return of 3.85% over the past week, outperforming the Sensex, which returned 1.41%. However, over the past month, th..."
      },
      {
        "title": "Senores Pharmaceuticals Shows Strong Rebound Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-stock-rises-7-21-amid-broader-market-decline-1184355",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/SenoresPharmace_priceRelatedfactors_573973.png",
        "date": "2025-03-04 14:35:29",
        "description": "Senores Pharmaceuticals experienced a notable rebound today, rising significantly after two days of decline. The stock outperformed its sector and is trading above key moving averages, indicating a positive short-term trend. Meanwhile, the broader market, including the Sensex, remains under pressure, with small-cap stocks showing relative strength."
      },
      {
        "title": "Senores Pharmaceuticals Demonstrates Strong Resilience Amid Broader Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-stock-rises-7-83-outperforming-sector-amid-market-decline-1078300",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/SenoresPharmace_priceRelatedfactors_504853.png",
        "date": "2025-02-21 14:20:24",
        "description": "Senores Pharmaceuticals has demonstrated strong performance, gaining 7.83% on February 21, 2025, and outperforming its sector significantly. The stock has seen a total return of 13.38% over three days and is trading above multiple moving averages, indicating a positive trend amid broader market challenges."
      },
      {
        "title": "Senores Pharmaceuticals Faces Volatility Amidst Declining Stock Performance and Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-stock-declines-7-17-amid-consecutive-losses-and-high-volatility-911288",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/SenoresPharmace_priceRelatedfactors_396914.png",
        "date": "2025-02-10 10:20:31",
        "description": "Senores Pharmaceuticals has faced notable stock volatility on February 10, 2025, with a significant decline marking its second consecutive day of losses. The stock reached an intraday low and exhibited high fluctuations, while maintaining positions above several moving averages. Recent performance contrasts with a slight decline in the broader market."
      },
      {
        "title": "Senores Pharmaceuticals Shows Strong Market Position Amid Broader Market Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-stock-rises-8-31-on-february-6-2025-outperforming-sector-764635",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/SenoresPharmace_priceRelatedfactors_373542.png",
        "date": "2025-02-06 10:05:41",
        "description": "Senores Pharmaceuticals has demonstrated notable market activity, with a significant stock increase and strong performance metrics. The company has outperformed its sector and the broader Sensex, achieving consecutive gains over the past three days and trading above multiple moving averages, indicating a positive price trend."
      }
    ],
    "total": 15,
    "sid": "10039497",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/senores-pharmaceuticals-10039497"
  },
  "announcements": [
    {
      "caption": "Intimation For Change In Corporate Identity Number (CIN) And Listing Status Of Senores Pharmaceuticals Limited (Company) On The Ministry Of Corporate Affairs (MCA) Portal.",
      "datetime": "04-Apr-2025",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange that pursuant to listing of the equity shares of the Company the Corporate Identity Number (CIN) and Listing Status have been updated in the master data maintained by Ministry of Corporate Affairs(MCA).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Apr-2025",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange Schedule of Analyst/Investor meeting on April 09 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Apr-2025",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange about certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Senores Pharmaceuticals Achieves 52-Week High Amid Strong Small-Cap Market Performance

2025-03-19 09:53:05

Senores Pharmaceuticals has achieved a new 52-week high of Rs. 664, reflecting a strong performance with a notable increase over the past three days. The stock is trading above multiple moving averages, indicating positive momentum, while the broader market shows small-cap stocks leading the gains.

Senores Pharmaceuticals Achieves 52-Week High Amid Strong Small-Cap Market Sentiment

2025-03-19 09:53:05

Senores Pharmaceuticals has achieved a new 52-week high of Rs. 664, marking a significant milestone for the small-cap company in the Pharmaceuticals & Drugs sector. The stock has shown strong performance, trading above key moving averages and demonstrating substantial recovery from its previous low of Rs. 440.

Senores Pharmaceuticals Achieves All-Time High Stock Price, Signaling Strong Market Momentum

2025-03-19 09:32:34

Senores Pharmaceuticals has achieved an all-time high stock price of Rs. 650, marking a significant milestone for the small-cap company. The stock has outperformed its sector and the broader market, showing strong upward trends and notable volatility, with impressive returns over the past week and year-to-date.

Senores Pharmaceuticals Shows Strong Performance Amid Small-Cap Market Rally

2025-03-18 15:16:12

Senores Pharmaceuticals has experienced notable activity, trading close to its 52-week high and showing strong performance in the small-cap pharmaceuticals sector. The stock has outperformed its sector and the broader market, reflecting a positive trend with significant gains over the past week and month.

Senores Pharmaceuticals Faces Mixed Technical Indicators Amid Market Volatility

2025-03-11 08:05:55

Senores Pharmaceuticals, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 551.00, down from a previous close of 566.10, with a 52-week high of 644.40 and a low of 440.00. Today's trading saw a high of 573.25 and a low of 540.85, indicating some volatility in its performance. In terms of technical indicators, the company shows a mixed picture. The Moving Averages are being monitored closely, while other metrics such as MACD, RSI, and Bollinger Bands are also part of the ongoing analysis. Notably, the Dow Theory and On-Balance Volume (OBV) indicate no clear trend at this time. When comparing the stock's performance to the Sensex, Senores Pharmaceuticals has shown a return of 3.85% over the past week, outperforming the Sensex, which returned 1.41%. However, over the past month, th...

Senores Pharmaceuticals Shows Strong Rebound Amid Broader Market Decline

2025-03-04 14:35:29

Senores Pharmaceuticals experienced a notable rebound today, rising significantly after two days of decline. The stock outperformed its sector and is trading above key moving averages, indicating a positive short-term trend. Meanwhile, the broader market, including the Sensex, remains under pressure, with small-cap stocks showing relative strength.

Senores Pharmaceuticals Demonstrates Strong Resilience Amid Broader Market Challenges

2025-02-21 14:20:24

Senores Pharmaceuticals has demonstrated strong performance, gaining 7.83% on February 21, 2025, and outperforming its sector significantly. The stock has seen a total return of 13.38% over three days and is trading above multiple moving averages, indicating a positive trend amid broader market challenges.

Senores Pharmaceuticals Faces Volatility Amidst Declining Stock Performance and Market Fluctuations

2025-02-10 10:20:31

Senores Pharmaceuticals has faced notable stock volatility on February 10, 2025, with a significant decline marking its second consecutive day of losses. The stock reached an intraday low and exhibited high fluctuations, while maintaining positions above several moving averages. Recent performance contrasts with a slight decline in the broader market.

Senores Pharmaceuticals Shows Strong Market Position Amid Broader Market Trends

2025-02-06 10:05:41

Senores Pharmaceuticals has demonstrated notable market activity, with a significant stock increase and strong performance metrics. The company has outperformed its sector and the broader Sensex, achieving consecutive gains over the past three days and trading above multiple moving averages, indicating a positive price trend.

View All News

Announcement

Intimation For Change In Corporate Identity Number (CIN) And Listing Status Of Senores Pharmaceuticals Limited (Company) On The Ministry Of Corporate Affairs (MCA) Portal.

04-Apr-2025 | Source : BSE

Senores Pharmaceuticals Limited has informed the Exchange that pursuant to listing of the equity shares of the Company the Corporate Identity Number (CIN) and Listing Status have been updated in the master data maintained by Ministry of Corporate Affairs(MCA).

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

03-Apr-2025 | Source : BSE

Senores Pharmaceuticals Limited has informed the Exchange Schedule of Analyst/Investor meeting on April 09 2025.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

03-Apr-2025 | Source : BSE

Senores Pharmaceuticals Limited has informed the Exchange about certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025.